These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17715204)

  • 1. Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents.
    Ojala K; Repo-Tiihonen E; Tiihonen J; Niskanen L
    J Psychopharmacol; 2008 Jan; 22(1):33-8. PubMed ID: 17715204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with statins and omega-3 fatty acids.
    Nambi V; Ballantyne CM
    Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of statins in the treatment of diabetic dyslipidemia.
    Berriche O; Amrouche C; Jamoussi H; Blouza S
    Tunis Med; 2010 Feb; 88(2):80-4. PubMed ID: 20415163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
    Goldberg AC; Bittner V; Pepine CJ; Kelly MT; Thakker K; Setze CM; Lele A; Sleep DJ
    Am J Cardiol; 2011 Mar; 107(6):898-905. PubMed ID: 21247520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2008 May; 28(5):562-9. PubMed ID: 18447654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the lipid profile of dyslipidemic subjects.
    Kolovou GD; Anagnostopoulou KK; Damaskos DS; Bilianou HI; Mihas C; Milionis HJ; Kostakou PM; Cokkinos DV
    Eur J Intern Med; 2009 Mar; 20(2):145-51. PubMed ID: 19327602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients.
    Tsouchnikas I; Dounousi E; Papakonstantinou S; Ioannou K; Kelesidis A; Kotzadamis N; Xanthopoulou K; Tsakiris D
    Nephrology (Carlton); 2009 Sep; 14(6):560-4. PubMed ID: 19422526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study.
    Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M
    Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.